Answers are grounded in this paper and cite their sources.
Allogeneic hematopoietic cell transplantation (HCT) improves outcomes for patients with AML harboring an internal tandem duplication mutation of
No takes yet. Share an insight, caveat, or question.
Levis et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: